Glaxosmithkline is extending its product portfolio in the Middle East. The company has acquired the branded generics business of Bristol-Myers Squibb in Lebanon, Jordan, Syria, Libya and Yemen for a cash consideration of $23.2 million.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Ineos CEO Ineos calls on European politicians to save the chemical industry.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
